+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica



Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica



Veterinary Record Open 5(1): E000285



Three groups of approximately eight-week-old beagles were vaccinated once with 1 ml of placebo vaccine (oral, n=9), 1 ml of Recombitek® Oral Bordetella (oral, n=10) or 1 ml Nobivac® Intra-Trac3 (intranasal, 0.5 ml/nostril, n=10). Seven days after vaccination, the three groups were challenged with virulent Bordetella bronchiseptica via aerosolisation. Eight of nine dogs in the placebo group and no dogs in the Recombitek® Oral Bordetella or Nobivac® Intra-Trac3 vaccine groups developed spontaneous cough of two or more consecutive days (disease case definition). Dogs in the Recombitek® Oral Bordetella and Nobivac® Intra-Trac3 groups had a significantly lower incidence of disease (P<0.0001) with a 100 per cent preventable fraction. The study demonstrated that vaccination with either Recombitek® Oral Bordetella or Nobivac® Intra-Trac3 is effective in preventing disease seven days after vaccination when compared with dogs vaccinated with a placebo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065733906

Download citation: RISBibTeXText

PMID: 30167313

DOI: 10.1136/vetreco-2018-000285


Related references

Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs. Veterinary Journal 212: 71-77, 2016

Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine. American Journal of Veterinary Research 40(9): 1241-1243, 1979

Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchiseptica. Vaccine 27(18): 2523-2528, 2008

Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours. Veterinary Record 156(15): 482-483, 2005

Interaction between immunity to Bordetella bronchiseptica and infection of pig herds by Bordetella bronchiseptica and Pasteurella multocida. Journal of Veterinary Medical Science 55(4): 617-622, 1993

Serum haptoglobin concentration in growing swine after intranasal challenge with Bordetella bronchiseptica and toxigenic Pasteurella multocida type D. Canadian Journal of Veterinary Research 60(3): 222-227, 1996

Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. Veterinary Therapeutics 9(4): 257-262, 2008

Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. Veterinary Therapeutics: 4, 257-262, 2008

AroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge. Research in Veterinary Science 94(1): 55-61, 2013

Serological and protective activities of bordetella pertussis bordetella parapertussis and bordetella bronchiseptica vaccines. Indian Journal of Medical Research 74(DEC): 815-820, 1981

Comparative studies into two Bordetella-bronchiseptica-live vaccines: Animal model. Monatshefte fuer Veterinaermedizin 49(3): 127-133, 1994

Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Vaccine 28(27): 4362-4368, 2010

Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge. Journal of Veterinary Internal Medicine 26(5): 1121-1125, 2013

Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Microbiology and Immunology 60(9): 599-608, 2016

Comparative analysis of the virulence control systems of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Abstracts of the General Meeting of the American Society for Microbiology 97: 84, 1997